DXCMDexCom, Inc.
72.65USD+0.76%Mkt Cap: 27.95B USDP/E: 31.09Last update: 2026-05-26

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States an…

Indicators:|

Key Statistics

Company
Market Cap27.95B USD
Enterprise Value26.71B USD
Revenue (TTM)4.82B USD
Gross Profit2.80B USD
Net Income (TTM)836.30M USD
Revenue/Share12.39 USD
Last Price72.65 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS2521311074
Valuation
P/E (Trailing)31.09
P/E (Forward)23.57
PEG1.33
EV/EBITDA20.67
EV/Revenue5.54
P/S5.76
P/B9.38
EPS (TTM)2.33
EPS (Forward)3.05
52W Range
54.1152% of range89.98
52W High89.98 USD
52W Low54.11 USD
Profitability
Gross Margin60.10%
Oper. Margin21.42%
EBITDA Margin26.82%
Profit Margin17.94%
ROE30.46%
ROA13.19%
Growth
Revenue Growth15.00%
Earnings Growth92.20%
Cash Flow & Leverage
Operating CF1.44B USD
CapEx (TTM)363.50M USD
FCF Margin21.93%
FCF Yield3.78%
Net Debt-1.03B USD
Net Debt/EBITDA-0.80
Balance Sheet
Debt/Equity0.51
Current Ratio1.95
Quick Ratio1.58
Book Value/Sh7.662 USD
Cash/Share6.259 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split4:1
Split DateJun 13, 2022
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)81.64 USD
Target Range64.00 USD112.00 USD
# Analysts25
Ownership
Shares Out.385.87M
Float384.08M
Insiders0.28%
Institutions102.69%
Short Interest
Short Ratio4.3d
Short % Float5.46%
Short % Out.4.75%
Shares Short18.32M
Short (prev mo.)14.72M
Technical
SMA 5063.32 (+14.7%)
SMA 20067.98 (+6.9%)
Beta1.40
S&P 52W Chg28.31%
Avg Vol (30d)6.26M
Avg Vol (10d)8.32M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)